Portfolio Alerts Watch List Cart

Pharmaceutical

Refine Search

Product Compare (0)
A
Achyut Healthcare Ltd
Score 58/100• Decent
Achyut Healthcare Ltd shows potential in a growing sector, but faces challenges in profitability and market sentiment.
Company’s Health70/100
Valuation 40/100 · PB 4.2822
Technical Avoid
1M -1.268% 6M 55.89% 1Y 5.566%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#136
View details ➜
T
TTK Healthcare Ltd
Score 57/100• Decent
TTK Healthcare Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
Company’s Health80/100
Valuation 80/100 · PB 1.4063
Technical Avoid
1M -7.753% 6M -17.136% 1Y -28.651%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#137
View details ➜
P
Piramal Pharma Ltd
Score 57/100• Decent
Piramal Pharma Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
Company’s Health56/100
Valuation 60/100 · PB 2.8393
Technical Avoid
1M -11.744% 6M -12.744% 1Y -30.719%
Confidence100%
No promoter pledgeReasonable PB valuation
Weak ROEThin margins
#138
View details ➜
K
Kerala Ayurveda Ltd
Score 57/100• Decent
Kerala Ayurveda Ltd shows potential in a growing sector, but faces challenges in execution and profitability.
Company’s Health22/100
Valuation 20/100 · PB 28.9342
Technical Avoid
1M -21.551% 6M -36.982% 1Y -17.722%
Confidence100%
Decent revenue growth
Weak ROEHigh debt/equity
#139
View details ➜
V
Vimta Labs Ltd
Score 56/100• Decent
Vimta Labs Ltd shows potential in a growing sector, but faces challenges in consistency and valuation. Caution is advised.
Company’s Health90/100
Valuation 20/100 · PB 7.082
Technical Avoid
1M -7.979% 6M 19.794% 1Y 29.094%
Confidence100%
Low leverage (D/E)No promoter pledge
#140
View details ➜
G
Gujarat Themis Biosyn Ltd
Score 56/100• Decent
Gujarat Themis Biosyn Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics. Caution is advised.
Company’s Health83/100
Valuation 20/100 · PB 16.817
Technical Avoid
1M -14.193% 6M 12.7% 1Y 60.191%
Confidence100%
Low leverage (D/E)Healthy profit margins
Promoter pledge present
#141
View details ➜
C
Cohance Lifesciences Ltd
Score 56/100• Decent
Cohance Lifesciences Ltd shows potential in a growing sector, but faces challenges in profitability and valuation. Caution is advised.
Company’s Health66/100
Valuation 20/100 · PB 11.1363
Technical Avoid
1M -23.525% 6M -46.914% 1Y -58.021%
Confidence100%
Low leverage (D/E)Healthy profit margins
Promoter pledge present
#142
View details ➜
O
Onyx Biotec Ltd
Score 56/100• Decent
Onyx Biotec Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics, warranting cautious investment.
Company’s Health89/100
Valuation 80/100 · PB 1.1084
Technical Avoid
1M -22.897% 6M -34.489% 1Y -38.35%
Confidence100%
Low leverage (D/E)No promoter pledge
Thin margins
#143
View details ➜
A
ANG Lifesciences India Ltd
Score 56/100• Decent
ANG Lifesciences India Ltd shows potential for growth but faces challenges in profitability and valuation. Caution is advised.
Company’s Health29/100
Valuation 100/100 · PB 0.6678
Technical Avoid
1M 0.613% 6M 9.067% 1Y -32.397%
Confidence100%
Reasonable PB valuation
Weak ROEPromoter pledge present
#144
View details ➜
R
Remus Pharmaceuticals Ltd
Score 54/100• Decent
Remus Pharmaceuticals Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Investors should be cautious.
Company’s Health91/100
Valuation 40/100 · PB 3.1432
Technical Avoid
1M -7.874% 6M -21.902% 1Y -39.708%
Confidence100%
Low leverage (D/E)No promoter pledge
Thin margins
#145
View details ➜
C
Coral Laboratories Ltd
Score 54/100• Decent
Coral Laboratories Ltd shows potential in a growing sector, but faces challenges in consistent growth and profitability.
Company’s Health87/100
Valuation 100/100 · PB 0.8211
Technical Avoid
1M -9.88% 6M -22.371% 1Y -41.424%
Confidence100%
Low leverage (D/E)No promoter pledge
#146
View details ➜
B
Biogen Pharmachem Industries Ltd
Score 54/100• Decent
Biogen Pharmachem Industries Ltd has a decent outlook with potential growth opportunities, but investors should be cautious due to execution risks and market sentiment.
Company’s Health42/100
Valuation 100/100 · PB 0.8444
Technical Avoid
1M -3.371% 6M -12.245% 1Y -33.846%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#147
View details ➜
S
Sudarshan Pharma Industries Ltd
Score 52/100• Decent
Sudarshan Pharma Industries Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks. Caution is advised for investors.
Company’s Health68/100
Valuation 40/100 · PB 4.4149
Technical Avoid
1M -6.344% 6M -21.176% 1Y -42.708%
Confidence100%
No promoter pledge
Thin margins
#148
View details ➜
I
IND Swift Laboratories Ltd
Score 52/100• Decent
The stock shows potential in a growing sector but faces several challenges that could impact future performance.
Company’s Health73/100
Valuation 100/100 · PB 0.6731
Technical Avoid
1M -7.039% 6M -11.201% 1Y -15.376%
Confidence100%
Low leverage (D/E)No promoter pledge
#149
View details ➜
V
Vasa Denticity Ltd
Score 48/100• Risky
Vasa Denticity Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health98/100
Valuation 20/100 · PB 15.0159
Technical Avoid
1M 2.105% 6M -6.728% 1Y -25.647%
Confidence100%
Low leverage (D/E)No promoter pledge
Thin margins
#150
View details ➜
Showing 136 to 150 of 260 (18 Pages)